Note to our followers: Our nearly 13-year run of daily publication of new content on came to a close at the end of 2018. Publisher Gary Schwitzer and other contributors may post new articles periodically. But all of the 6,000+ articles we have published contain lessons to help you improve your critical thinking about health care interventions. And those will be still be alive on the site for a couple of years.

The costs of medicalization and disease-mongering

Nice job by Jeremy Cox in the Florida Times-Union (Jacksonville) highlighting overlapping issues of disease-mongering, medicalization and health care costs.


If Americans would stop thinking of certain problems in a medical context, experts argue, it might chip away at the more than $2 trillion the nation spends annually on health care. Furthermore, people would be healthier because they would avoid some of the problems caused by too much health care, such as hospital-acquired infections and bad drug interactions.

A provocative new study for the first time puts a dollar figure to all the treatments, pills and procedures Americans seek to cure their formerly non-medical ills: $77.1 billion, in 2005 dollars.

That total represents less than 4 percent of the annual medical spending tab, but it’s more than the country spends on heart disease, cancer and public-health campaigns, Peter Conrad, a sociologist at Brandeis University and the lead author of the study, which was published in the journal Social Science and Medicine, said in an e-mail.

Kudos to Cox and his paper for making time and space for this. Newspapers could have a daily column on this topic. And I’d bet it’d be good for circulation!

You might also like


Please note, comments are no longer published through this website. All previously made comments are still archived and available for viewing through select posts.

Ken Leebow

July 9, 2010 at 3:43 pm

Re: If Americans would stop thinking of certain problems in a medical context…
That’s great, however, when firms like Merck make a disease out of osteopenia and subsequently turn it into a multi-billion dollar business, we the consumer don’t stand a fighting chance.
It pays to be informed.
Ken Leebow